ARYx Therapeutics Presents Clinical Data for ATI-5923 at American - Marke bi13511964 ARYx Therapeutics Presents Data for ATI-5923 at American MarketWatch - Nov 14, 2008 announced today that data for ATI-5923, a novel vitamin K epoxide reductase (VKOR) inhibitor Phase 2/3 development for the treatment of patients ARYx Therapeutics Presents Data for ATI-5923 at American Centre Daily Times all 8 news articles..

Former First Lady Rosalynn Carter Addresses Magellan Health - MarketWatch bi13511964 Former First Lady Rosalynn Carter Addresses Magellan Health MarketWatch - Nov 14, 2008 "It was an honor to host Mrs. Carter at Magellan's annual excellence conference," said Rene Lerer, MD, president and chief executive officer of ..

Clinical Anelka gives Chelsea relief from drama of Drogba - Independent bi13511964 SkySports Anelka gives Chelsea relief from drama of Drogba Independent, UK - 42 minutes ago His first had come a dink over Carson when put through by an opportunistic Salomon Kalou header. That was that, although really shouldn't Chelsea outclass Albion Times Online WEST BROM 0, CHELSEA 3 French ace proves he's Anel of a striker News of the World West Brom 0 Chelsea 3 The Sun expressandstar.com - expressandstar.comall 324 news articles..

BIOTRONIK Announces Positive Clinical Trial Results at American - MarketW bi13511964 BIOTRONIK Announces Positive Trial Results at American MarketWatch - Nov 14, 2008 "Based on the results from large-scale trial, I believe remote monitoring may improve the way physicians care for patients implanted ..

Adeona Pharmaceuticals Announces Clinical Update and Third Quarter - Mark bi13511964 Adeona Pharmaceuticals Announces Update and Third Quarter MarketWatch - Nov 14, 2008 Presentation by our scientific collaborator has presented new findings from a phase IIa trial results using estriol for the treatment of multiple ..

Clinical Pirates leave Chiefs all at sea - AFP bi13511964 AFP Pirates leave Chiefs all at sea AFP - 4 hours ago MAFIKENG, South Africa (AFP) ? Orlando Pirates scored twice 11 minutes during the first half for a 2-0 win over arch foes Kaizer Chiefs a Soweto ..

Biodel Reports Protective Effects of VIAject(TM) Insulin on - MarketWatch bi13511964 Biodel Reports Protective Effects of VIAject(TM) Insulin on MarketWatch - 11 hours ago These results are encouraging and warrant further study to investigate potential beneficial effects of ultra-rapid-acting insulin on microvascular ..

Lpath, Inc. to Provide Third Quarter 2008 Business Review and - MarketWatch bi13511964 Lpath, Inc. to Provide Third Quarter 2008 Business Review and MarketWatch - Nov 14, 2008 will host a teleconference on Wednesday, November 19 at 11:00am EST to provide a third quarter business review and update. Lpath, Inc. to Provide Third Quarter 2008 Business Review and Market Wire (press release) Lpath, Inc. to Provide Third Quarter 2008 Business Review and International Business Times all 9 news articles..

StemCells, Inc. Announces Four Presentations at Society for - WELT ONLINE bi13511964 StemCells, Inc. Announces Four Presentations at Society for WELT ONLINE, Germany - Nov 14, 2008 StemCells, Inc. a -stage biotechnology company focused on the discovery, development and commercialization of cell-based therapeutics to treat ..

Cardio-Cor Has Success Completing First Phase of Clinical Trials - MarketW bi13511964 Cardio-Cor Has Success Completing First Phase of Trials MarketWatch - Nov 13, 2008 Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc., stated, "The first phase of the trials has been successfully completed; ..

Providence Health & Services Wins Award from VHA for Improving - PR-Insid bi13511964 Providence Health & Services Wins Award from VHA for Improving PR-Inside.com (Pressemitteilung), Austria - Nov 14, 2008 'Sentri7 an excellent example of how advanced information technology simultaneously can promote enhanced quality and reduced costs, ..

Arizona Heart Institute gets a leg up human clinical trials - Bizjournal bi13511964 Arizona Heart Institute gets a leg up human trials Bizjournals.com, NC - Nov 14, 2008 The Arizona Heart Institute moving the next phase of human trials on a procedure leg-muscle cells are injected damaged hearts ..

Adeona Pharmaceuticals to Provide Clinical Update and Report Third - Mark bi13511964 Adeona Pharmaceuticals to Provide Update and Report Third MarketWatch - Nov 13, 2008 a specialty pharmaceutical company developing innovative stage drug candidates for the treatment of autoimmune and central nervous system (CNS), ..

Genuine Honda Accessories - Home